The role of nerve growth factor in caspase-dependent apoptosis in human BE(2)C neuroblastoma

Journal of Pediatric Surgery

Volumn 46, Issue 6, 2011, Pages 1191-1196

  Holub, Janette L ^a,b   Qiu, Yi Yong ^a   Chu, Fei ^a   Madonna, Mary Beth ^a,b  

^a Children's Memorial Research Center   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspase; Nerve growth factor; Neuroblastoma

Indexed keywords

CASPASE 3; DNA FRAGMENT; NERVE GROWTH FACTOR; PROTEIN P75; PROTEIN TYROSINE KINASE A; CASPASE; DEATH RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR P75;

APOPTOSIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING; WILD TYPE; CELL DIFFERENTIATION; CELL TYPE; NOTE; ONCOGENE C MYB;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL SURVIVAL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NERVE GROWTH FACTORS; NEUROBLASTOMA; RECEPTOR, TRKA; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 79959307573     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.03.054     Document Type: Article

References (22)

1. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: JB Lippincott Company; 2006. p. 933-70.
2. Park JR, et al. Neuroblastoma: biology, prognosis and treatment. Pediatr Clin of NA 2008;55:97-120.
3. Goldsby RE, Matthay KK. Neuroblastoma: evolving therapies for a disease with many faces. Pediatr Drugs 2004;6:107-22.
4. Verdi JM, Anderson DJ. Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts. Neuron 1994;13:1359-72.
5. Aloe L, et al. Nerve growth factor in neurological and nonneurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Design 2001;7:113-23. (Pubitemid 32409710)
6. Levi A, Alema S. The mechanism of action of nerve growth factor. Annu Rev Pharmacol Toxicol 1991;31:205-28. (Pubitemid 21903847)
7. Kleese LJ, et al. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene 1999;18:2055-68.
8. Brodeur GM. Trk-A expression in neuroblastomas: a new prognostic marker with biological and clinical significance. JNCI 1992;85:344-5.
9. Lavenius E, et al. Transfection of Trk-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differen 1995;6:727-36.
10. Woo CW, et al. NGF activation of Trk A decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 2004;23:1522-30.
11. Eggert A, Sieverts H, Ikegaki N, et al. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA. Med Pediatr Oncol 2000;35:573-6.
12. Kuner P, Hertel C. NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR. J Neurosci Res 1998;54:465-74. (Pubitemid 28507025)
13. Castellon R, Mirkin BL. Retroviral transfer of the B-nerve growth factor gene into murine neuroectodermal tumor cells modulates cell proliferation rate, neurite formation, and NGF binding site expression. J Neurosci Res 2000;59:265-75. (Pubitemid 30036900)
14. Nagata S. Apoptosis by death receptor. Cell 1997;88:355-65.
15. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12. (Pubitemid 28406816)
16. Yakovlev AG, Ota K, Wang G, et al. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 2001;21:7439-46. (Pubitemid 32904942)
17. Liu W, Wang G, Yakovlev AG. Identification and functional analysis of the rat caspase-3 gene promoter. J Biol Chem 2002;277:8273-8. (Pubitemid 34968286)
18. Lachyankar MB, Condon PJ, Daou MC, et al. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells. J Neurosci Res 2003;71(2):157-72. (Pubitemid 36055461)
19. Giraud C, Lautrette C, Bessette B, et al. Modulation of Fas-induced apoptosis by p75 neurotrophin receptor in a human neuroblastoma cell line. Apoptosis 2005;10:1271-83. (Pubitemid 43117675)
20. Lievremont JP, Sciorati C, Morandi E, et al. The p75ntr-induced apoptotic program develops through a ceramide-caspase pathway negatively regulated by nitric oxide. J Biol Chem 1999;274:15466-72.
21. Jung EJ, Lim DR. Apoptotic cell death in Trk A-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation. Mol Cells 2008;26:12-7.
22. Dominici C, Nicotra MR, Alema S, et al. Immunohistochemical detection of p140 TrkA and p75 LNGR neurotrophin receptors in neuroblastoma. J Neurooncol 1997;30:57-64. (Pubitemid 27077710)